MedPath

University of California, Los Angeles

University of California, Los Angeles logo
🇺🇸United States
Ownership
Private, Subsidiary
Established
1919-05-23
Employees
10K
Market Cap
-
Website
http://www.ucla.edu

Ocular Imaging Study Using Advanced OCT

Conditions
Macular Degeneration
Retinal Vascular Disorder
First Posted Date
2016-07-11
Last Posted Date
2016-07-11
Lead Sponsor
University of California, Los Angeles
Target Recruit Count
1000
Registration Number
NCT02827071
Locations
🇺🇸

Stein Eye Institute/Geffen School of Medicine, Los Angeles, California, United States

Enhancing Cognitive Training Through Exercise Following a First Schizophrenia Episode

Not Applicable
Completed
Conditions
Schizophrenia
Schizophreniform Disorder
Schizoaffective Disorder
Interventions
Behavioral: Cognitive Training
Behavioral: Aerobic Exercise
Behavioral: Case management and supportive psychotherapy
Behavioral: Individual Placement and Support
First Posted Date
2016-07-06
Last Posted Date
2023-11-27
Lead Sponsor
University of California, Los Angeles
Target Recruit Count
100
Registration Number
NCT02823041
Locations
🇺🇸

University of California, Los Angeles, Los Angeles, California, United States

Measuring and Monitoring Adherence to ART With Pill Ingestible Sensor System

Not Applicable
Completed
Conditions
Medication Adherence
HIV/AIDS
Interventions
Device: Proteus digital health feedback (PDHF) system
First Posted Date
2016-06-13
Last Posted Date
2021-12-20
Lead Sponsor
University of California, Los Angeles
Target Recruit Count
130
Registration Number
NCT02797262
Locations
🇺🇸

LA BioMed, Los Angeles, California, United States

Study to Compare Palindrome vs. BioFlo DuraMax Dialysis Catheters

Not Applicable
Terminated
Conditions
Chronic Kidney Disease
Interventions
Device: Palindrome Dialysis Catheter
Device: Bioflo Dialysis Catheter
First Posted Date
2016-06-10
Last Posted Date
2020-08-13
Lead Sponsor
University of California, Los Angeles
Target Recruit Count
32
Registration Number
NCT02796300
Locations
🇺🇸

UCLA Medical Center, Los Angeles, California, United States

Imaging Innovations for Placental Assessment in Response to Environmental Pollution (PARENTs)

Completed
Conditions
Placental Disease
First Posted Date
2016-06-01
Last Posted Date
2021-05-04
Lead Sponsor
University of California, Los Angeles
Target Recruit Count
199
Registration Number
NCT02786420
Locations
🇺🇸

University of California, Los Angeles, Los Angeles, California, United States

Polyglactin 910 vs Poligelecaprone 25 Running Subcuticular Closure of Elliptical Excision Wounds

Not Applicable
Withdrawn
Conditions
Cosmetics, Suture, Cicatrix
Interventions
Procedure: running subcuticular closure of excisional defect
First Posted Date
2016-05-18
Last Posted Date
2017-05-17
Lead Sponsor
University of California, Los Angeles
Registration Number
NCT02776618
Locations
🇺🇸

Department of Dermatology, University of California, Los Angeles, Los Angeles, California, United States

Exogenous Sodium Lactate Infusion in Traumatic Brain Injury (ELI-TBI)

Phase 2
Withdrawn
Conditions
Brain Injuries, Traumatic
Interventions
First Posted Date
2016-05-18
Last Posted Date
2021-11-15
Lead Sponsor
University of California, Los Angeles
Registration Number
NCT02776488
Locations
🇺🇸

David Geffen School of Medicine at UCLA, Los Angeles, California, United States

Glutamate, Learning, and Working Memory

Phase 1
Completed
Conditions
Schizophrenia
Interventions
Other: Placebo
Drug: D-cycloserine
First Posted Date
2016-05-12
Last Posted Date
2016-05-12
Lead Sponsor
University of California, Los Angeles
Target Recruit Count
110
Registration Number
NCT02769936

The Impact of Family Financial Support on Child Health

Not Applicable
Completed
Conditions
Child Overall Health Related Quality of Life
Interventions
Behavioral: Access to Referral to Social Services
Behavioral: Financial Coaching
First Posted Date
2016-05-12
Last Posted Date
2017-10-26
Lead Sponsor
University of California, Los Angeles
Target Recruit Count
150
Registration Number
NCT02770144
Locations
🇺🇸

LIFT-LA, Los Angeles, California, United States

Characterization of the Analgesic Effect of CBD in Healthy, Normal Volunteers

Phase 1
Completed
Conditions
Pain
Interventions
Drug: Placebo
Drug: Cannabidiol
First Posted Date
2016-04-26
Last Posted Date
2021-05-12
Lead Sponsor
University of California, Los Angeles
Target Recruit Count
18
Registration Number
NCT02751359
Locations
🇺🇸

Cooper, New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath